P von Löwis, U H Klemens. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAdultAgedAlanine Transaminase/bloodAmbulatory CareAnticoagulants/therapeutic useAspartate Aminotransferases/bloodBody WeightCholesterol/bloodClofibrate/administration & dosageClofibrate/adverse effectsClofibrate/therapeutic useDrug EvaluationDrug SynergismFemaleHumansHypercholesterolemia/drug therapyHyperlipidemias/drug therapyHypolipidemic Agents/therapeutic useLipoproteins/bloodLipoproteins, VLDL/bloodMaleMiddle AgedPlacebosTransaminases/bloodTriglycerides/blood
Substances: See more » AnticoagulantsHypolipidemic AgentsLipoproteinsLipoproteins, VLDLPlacebosTriglyceridesCholesterolTransaminasesAspartate AminotransferasesAlanine TransaminaseClofibrate
Year: 1973 PMID: 4357927 DOI: 10.1055/s-0028-1107251
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN: 0012-0472 Impact factor: 0.628